ESMO-Virtual-Advanced-Course-on-Liquid-biopsy-1000x250

Start date: 15 Jun 2021
End date: 16 Jun 2021
Location: Virtual, CEST Time

Learning objectives

To understand the principles of blood-based liquid biopsies and the available methodologies for isolating tumor material from blood samples
To review and discuss data for liquid biopsy-based assessments as endpoints of antitumor activity in clinical trials
To understand the potential and limitations of liquid biopsy-based tumor genomic profiling for patient stratification and detection of predictive biomarkers of response to therapy
To learn how the assessment of tumor heterogeneity and evolution based on liquid biopsy assays can improve cancer treatment

Accreditation

The programme of this event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

Joaquin Mateo, Spain
Ryan Corcoran, United States

Learning objectives

Accreditation

Co-Chairs

Supported by